We are live on ! Find out more
YCBD icon

cbdMD
YCBD

2 hedge funds and large institutions have $74K invested in cbdMD in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more capital invested

Capital invested by funds: $66K → $74K (+$8K)

0% more funds holding

Funds holding: 2 → 2 (0)

0% more ownership

Funds ownership: 0% → 0% (+0%)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$73K

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$49K
2
UBS Group
UBS Group
Switzerland
-$14K
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
1
Millennium Management
New York
$71K +$73K +47 New
UBS Group
2
UBS Group
Switzerland
$3K -$14K -9 -82%
Goldman Sachs
3
Goldman Sachs
New York
– -$49K -31 Closed

YCBD Hedge Fund Activity: Q1 2018 in Review

2 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in cbdMD (YCBD) for Q1 2018, worth a combined $74K — up 12% from $66K a quarter earlier.

Fund positioning in YCBD was balanced in Q1 2018: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 1 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $73K. The largest seller was Goldman Sachs, exiting entirely with an estimated $49K sold.

  • 2 institutional investors held cbdMD (YCBD) as of Q1 2018, unchanged from Q4 2017.
  • Funds reported $74K of cbdMD stock for Q1 2018, up 12% quarter-over-quarter.
  • 1 fund opened new cbdMD positions in Q1 2018 and 1 closed out, a net change of 0 holders.
  • The largest cbdMD buyer in Q1 2018 was Millennium Management, an estimated $73K added.
  • The largest cbdMD seller in Q1 2018 was Goldman Sachs, an estimated $49K sold.

Based on aggregated 13F filings for Q1 2018.